BMRN icon

BioMarin Pharmaceuticals
BMRN

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$82
47% upside
High target

3 analyst ratings

positive
1  neutral
33%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
BofA Securities
BofA Securities
Geoff Meacham
0% 1-yr BMRN win rate
11 Mar ‘26 2 months ago
Barclays
Barclays
Eliana Merle
0% 1-yr BMRN win rate
4 Mar ‘26 2 months ago
HC Wainwright & Co
HC Wainwright & Co
Mitchell Kapoor
2 Mar ‘26 3 months ago